Bank Of America Corp Replimune Group, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Replimune Group, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 108,908 shares of REPL stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,908

Previous 84,674 28.62%

Holding current value

$1.63 Million

Previous $762,000 56.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $196,053 - $272,147	24,234 Added 28.62%	108,908 $1.19 Million
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $1.53 Million - $2.89 Million	-305,357 Reduced 78.29%	84,674 $762,000
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $1.16 Million - $1.58 Million	169,384 Added 76.77%	390,031 $3.19 Million
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $792,004 - $1.9 Million	117,334 Added 113.57%	220,647 $1.86 Million
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $2.82 Million - $4.34 Million	-180,005 Reduced 63.53%	103,313 $2.4 Million
Q1 2023 May 12, 2023	BUY	$17.48 - $29.09 $3.34 Million - $5.55 Million	190,823 Added 206.31%	283,318 $5 Million
Q4 2022 Feb 10, 2023	BUY	$17.09 - $27.91 $361,624 - $590,575	21,160 Added 29.66%	92,495 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $137,467 - $186,373	8,812 Added 14.09%	71,335 $1.23 Million
Q2 2022 Aug 12, 2022	SELL	$13.32 - $19.98 $133,945 - $200,918	-10,056 Reduced 13.86%	62,523 $1.09 Million
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $783,259 - $1.53 Million	51,395 Added 242.61%	72,579 $1.23 Million
Q4 2021 Feb 08, 2022	BUY	$25.43 - $34.25 $318,790 - $429,358	12,536 Added 144.96%	21,184 $574,000
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $17,938 - $24,475	-619 Reduced 6.68%	8,648 $256,000
Q2 2021 Sep 13, 2021	BUY	$28.5 - $39.37 $264,109 - $364,841	9,267 New	9,267 $356,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $736M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Replimune Group, Inc. Transaction History